Nerve News and Research

RSS

InVivo Therapeutics reports net loss of $1,278,000 for first quarter 2011

InVivo Therapeutics, a medical device company focused on the development of groundbreaking technologies for the treatment of spinal cord injuries, today reported financial results for the first quarter 2011.

16 May 2011

Scientists discover single neuron that enables adaptive regulation of sparseness in olfactory codes

The brain is a coding machine: it translates physical inputs from the world into visual, olfactory, auditory, tactile perceptions via the mysterious language of its nerve cells and the networks which they form. Neural codes could in principle take many forms, but in regions forming bottlenecks for information flow or in areas important for memory, sparse codes are highly desirable.

16 May 2011

Australian TGA approves Biogen Idec's FAMPYRA to improve walking ability in patients with MS

The Australian Therapeutic Goods Administration (TGA) has granted approval for FAMPYRA, (fampridine) 10 mg Modified Release (MR) tablet, for the symptomatic improvement of walking ability in adult patients with multiple sclerosis (MS) who have shown improvement after eight weeks of treatment.

16 May 2011

Evidence of damaged baby brains & inadequate anesthetic induced sleep: Conference updates

According to new studies commonly used anesthetics may be causing brain damage in people, especially babies who receive them while their brains are still developing.

15 May 2011

Researchers untangle two distinct ways in which tumor-suppressor protein works

Researchers at the Stanford University School of Medicine have untangled two distinct ways in which a common, naturally occurring "tumor-suppressor" protein works.

13 May 2011

Study offers hints to why Parkinson's so selectively harms dopamine-producing cells

New data offer hints to why Parkinson's disease so selectively harms brain cells that produce the chemical dopamine, say researchers at Washington University School of Medicine in St. Louis.

13 May 2011

New method for mapping myelin sheaths of nerve cells

Researchers including members from the Niels Bohr Institute at the University of Copenhagen have developed a new method for making detailed X-ray images of brain cells.

13 May 2011

New clinical data affirms safety profile of PolyMedix's PMX-30063 in treatment of Staph infections

PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat life-threatening infectious diseases and acute cardiovascular disorders, presented new clinical and pre-clinical data related to the safety and efficacy of its novel, lead defensin-mimetic antibiotic, PMX-30063.

12 May 2011

Reprogrammed herpes virus can improve early cancer diagnosis

Scientists have used a genetically re-engineered herpes virus that selectively hunts down and infects cancerous tumors and then delivers genetic material that prompts cancers to secrete a biomarker and reveal their presence.

12 May 2011

Being mildly overweight benefits ALS patients

Patients with amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, may be an exception to the rule that being overweight is a health hazard. In a retrospective study of over 400 ALS patients, Massachusetts General Hospital researchers found that those who were mildly obese survived longer than patients who were normal weight, underweight or even overweight.

12 May 2011

Visual perception and attention can be changed by passive stimulation

What was previously known from animal studies has thus for the first time been demonstrated for human individuals too. "The findings open new perspectives in the intervention and treatment of visual perceptual disorders, because the changes can be induced quite simply" said Dr. Christian Beste of the RUB Institute of Cognitive Neuroscience.

12 May 2011

TSA, Psyadon Pharmaceuticals partner for ecopipam clinical trial in Tourette Syndrome

The national Tourette Syndrome Association and Psyadon Pharmaceuticals Inc. are pleased to announce their collaboration on a clinical trial to determine the potential efficacy of a novel drug, ecopipam, for managing the symptoms of the neurological disorder Tourette Syndrome.

11 May 2011

Pacira Pharmaceuticals reports net loss of $9.8 million for first quarter 2011

Pacira Pharmaceuticals, Inc., an emerging specialty pharmaceutical company, today announced financial results for the first quarter ended March 31, 2011, provided an update on the execution of its pre-commercial and launch strategies for EXPAREL, and reiterated 2011 financial guidance.

11 May 2011

Intensive exercise can help improve facial nerve damage

A research study conducted at Washington State University Spokane offers hope to those suffering from facial nerve damage. According to the study, which was published online this week in the journal Developmental Neurohabilitation, muscle weakness resulting from facial nerve damage incurred during childhood can improve with intensive facial exercise, years after injury.

11 May 2011

Second subject enrolled in human embryonic stem cell therapy trial for subacute thoracic spinal cord injury

Researchers at Northwestern Memorial Hospital, Northwestern University Feinberg School of Medicine and The Rehabilitation Institute of Chicago (RIC) recently enrolled their first subject in a national clinical research trial of a human embryonic stem cell-based therapy for participants with a subacute thoracic spinal cord injury.

11 May 2011

Insight into sensory recovery after face transplantation

Recovery of sensation after facial transplantation is similar to, or even better than, that achieved by conventional surgery to repair nerve injuries, reports a study in the May issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons.

10 May 2011

Dorsogluteal buttock site still most popular despite known potential for sciatic nerve injury

Seven out of ten hospital nurses who took part in a Canadian study used the dorsogluteal (DG) buttock site to administer intramuscular injections - despite the potential risks of sciatic nerve injury - with only 14% using the ventrogluteal (VG) hip site recommended by the nursing literature.

10 May 2011

Genetic mutation linked to Kufs disease

According to a new study, a genetic mutation thought to be responsible for the rare hereditary brain disorder Kufs disease is finally identified. The research was carried out by Dr Melanie Bahlo and her team at the Walter and Eliza Hall Institute's bioinformatics department in Parkville, Australia, in partnership with neurologist and epilepsy specialists Professor Sam Berkovic and Dr Todor Arsov from the University of Melbourne, Australia.

10 May 2011

Scientists reveal nerve cells' navigation system

Johns Hopkins scientists have discovered how two closely related proteins guide projections from nerve cells with exquisite accuracy, alternately attracting and repelling these axons as they navigate the most miniscule and frenetic niches of the nervous system to make remarkably precise connections.

9 May 2011

Young new nurses more likely to follow latest VG site advice to administer intramuscular injections

Seven out of ten hospital nurses who took part in a Canadian study used the dorsogluteal buttock site to administer intramuscular injections - despite the potential risks of sciatic nerve injury - with only 14% using the ventrogluteal hip site recommended by the nursing literature.

9 May 2011

Nerve News and Research

InVivo Therapeutics reports net loss of $1,278,000 for first quarter 2011

Scientists discover single neuron that enables adaptive regulation of sparseness in olfactory codes

Australian TGA approves Biogen Idec's FAMPYRA to improve walking ability in patients with MS

Evidence of damaged baby brains & inadequate anesthetic induced sleep: Conference updates

Researchers untangle two distinct ways in which tumor-suppressor protein works

Study offers hints to why Parkinson's so selectively harms dopamine-producing cells

New method for mapping myelin sheaths of nerve cells

New clinical data affirms safety profile of PolyMedix's PMX-30063 in treatment of Staph infections

Reprogrammed herpes virus can improve early cancer diagnosis

Being mildly overweight benefits ALS patients

Visual perception and attention can be changed by passive stimulation

TSA, Psyadon Pharmaceuticals partner for ecopipam clinical trial in Tourette Syndrome

Pacira Pharmaceuticals reports net loss of $9.8 million for first quarter 2011

Intensive exercise can help improve facial nerve damage

Second subject enrolled in human embryonic stem cell therapy trial for subacute thoracic spinal cord injury

Insight into sensory recovery after face transplantation

Dorsogluteal buttock site still most popular despite known potential for sciatic nerve injury

Genetic mutation linked to Kufs disease

Scientists reveal nerve cells' navigation system

Young new nurses more likely to follow latest VG site advice to administer intramuscular injections

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

How microplastics and bacteria interact to drive antibiotic resistance

Latest News